Revance, Mylan Move Forward With Botox Rival; Analyst Sees Long Path Ahead

After several postponed decisions, Mylan Inc (MYL) has announced that it is moving forward with a Botox biosimilar development program in collaboration with Revance Therapeutics (RVNC). On the news …
( read original story …)


Advertisement